Vo Nhung Thi Tuyet, Phan Trang Ngo Diem, Vo Trung Quang
Department of Pharmacy Administration, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City 700000, Vietnam.
Department of Pharmacy, Cu Chi General Hospital, Ho Chi Minh City 700000, Vietnam.
Malays J Med Sci. 2017 May;24(3):66-72. doi: 10.21315/mjms2017.24.3.8. Epub 2017 Jun 30.
In Vietnam, dengue fever is a major health concern, yet comprehensive information on its economic costs is lacking. The present study investigated treatment costs associated with dengue fever from the perspective of health care provision.
This retrospective study was conducted between January 2013 and December 2015 in Cu Chi General Hospital. The following dengue-related treatment costs were calculated: hospitalisation, diagnosis, specialised services, drug usage and medical supplies. Average cost per case and treatment cost across different age was calculated.
In the study period, 1672 patients with dengue fever were hospitalised. The average age was 24.98 (SD = 14.10) years, and 47.5% were males (795 patients). Across age groups, the average cost per episode was USD 48.10 (SD = 3.22). The highest costs (USD 56.61, SD = 48.84) were incurred in the adult age group (> 15 years), and the lowest costs (USD 30.10, SD = 17.27) were incurred in the paediatric age group (< 15 years).
The direct medical costs of dengue-related hospitalisation place a severe economic burden on patients and their families. The probable economic value of dengue management in Vietnam is significant.
在越南，登革热是一个主要的健康问题，但缺乏关于其经济成本的全面信息。本研究从医疗保健提供的角度调查了与登革热相关的治疗成本。
这项回顾性研究于2013年1月至2015年12月在古芝综合医院进行。计算了以下与登革热相关的治疗成本：住院、诊断、专科服务、药品使用和医疗用品。计算了每个病例的平均成本和不同年龄段的治疗成本。
在研究期间，1672例登革热患者住院。平均年龄为24.98岁（标准差=14.10），男性占47.5%（795例患者）。在各年龄组中，每例发作的平均成本为48.10美元（标准差=3.22）。成人年龄组（>15岁）的成本最高（56.61美元，标准差=48.84），儿童年龄组（<15岁）的成本最低（30.10美元，标准差=17.27）。
登革热相关住院的直接医疗成本给患者及其家庭带来了沉重的经济负担。越南登革热管理的潜在经济价值巨大。
